What are skin boosters, and how do these products differ?
“Skin booster” is a broad name for treatments aimed at skin quality, not one standardized formula. Some are hyaluronic acid (HA) fillers used for selected skin concerns rather than substantial volume or contour changes. Our guide to hyaluronic acid explains the difference between HA skincare and injectable gels.
Belotero Revive and Skinvive are HA-based products. They should not be treated as interchangeable with PN products or PLLA, PDLLA and CaHA collagen stimulators. For that wider distinction, see our comparison of skin-quality injectables and biostimulators.
Belotero Revive vs Skinvive vs Flore Aqua-s
| Product | Verified formulation | What the evidence means |
|---|---|---|
| Belotero Revive | Cross-linked HA 20 mg/mL with glycerol 17.5 mg/mL in the studied formulation. | Studied for early sun-related facial skin changes. Hydration benefits were clearest in dry-skin subgroups; this does not establish benefit for every skin type. |
| Skinvive by Juvéderm | Cross-linked HA 12 mg/mL with lidocaine 0.3% in the U.S. label. | Its current U.S. indications cover improved cheek smoothness and reduced neck lines in adults over 21. These are specific uses, not a general lifting or deep-repair claim. |
| Flore Aqua-s | The exact supplied formulation and current instructions were not verified for this comparison. | Ask for the full model name, ingredients and local instructions, including whether it contains lidocaine. Data for other Flore models cannot establish Aqua-s results or suitability. |
Skinvive’s U.S. neck indication was approved on 11 June 2026. U.S. authorization does not establish Thai-authorized use. Check the exact product offered in Thailand; do not substitute another Belotero model or assume that every Skinvive and Volite version has identical labeling.
Which gives more glow, and how long do results last?
The sources reviewed here do not establish a winner among all three. They study different patients, treatment plans and outcomes. HA concentration, country of origin and the presence of lidocaine cannot tell you which will look best or feel least painful.
- Belotero Revive: a study compared one-treatment and three-treatment plans for the same product. Its main hydration measure did not improve significantly across the full multiple-treatment group, although the dry-skin subgroup improved.
- Skinvive: its cheek study followed improvement through six months after initial treatment or an optional touch-up. This is not a six-month guarantee from one session.
- Flore Aqua-s: the information verified here is insufficient to support a specific onset, duration or comparison with the other two.
Early fullness may include swelling. Agree on a review based on the exact product, area and your response rather than automatic top-ups. None should be promised as an instant, event-ready treatment with no recovery time.
How should you compare suitability and cost in Thailand?
- Start with the concern. Dryness, fine lines, volume loss and loose skin need different assessments. Skincare or no injection may be the better option.
- Check the actual product. Ask the clinic to show its full name, Thai registration details, importer, lot number and expiry date, and explain whether the proposed use matches its local instructions.
- Compare the whole plan. Request an itemized quote covering the model, amount, any planned sessions, assessment and follow-up. A price per cc alone cannot establish value, and there is no standard amount suitable for everyone.
- Plan follow-up. Ask how to reach the treating doctor if symptoms develop, including outside clinic hours. Confirm instructions you understand for makeup, exercise, heat exposure and any other procedures.
Smooth Clinic’s official price page lists these options:
- Belotero Revive: 1 CC for THB 13,900; 2 CC for THB 25,000 total.
- Skinvive: 1 CC for THB 13,900; 2 CC for THB 25,000 total.
Confirm current prices and what is included before booking.
For current availability, a quote and an assessment, contact Smooth Clinic. A brand comparison cannot determine which treatment is right for you.
What risks and precautions matter?
Pain, swelling, bruising, redness and temporary bumps can occur. Infection, persistent lumps, delayed inflammation and allergic reactions are also possible. Sensitive skin or being a first-time patient does not make one brand automatically suitable.
Tell the doctor about allergies, medical conditions, medicines, supplements and previous injections. Lidocaine-containing products need particular attention if you have a lidocaine allergy; severe allergy history also matters. Do not stop prescribed medicines on your own. Discuss postponing elective treatment during pregnancy or breastfeeding because safety information is limited.
Postpone injections into skin with active infection or inflammation, including inflamed spots or a rash, until the cause has been assessed and treated or controlled. Increasing redness, warmth, pain, fever or discharge after treatment needs prompt medical assessment.
Accidental injection into a blood vessel can cause tissue damage, blindness or stroke. Seek immediate assessment for unusual or worsening pain, pale skin or dusky, mottled discoloration. If the treating doctor cannot assess you immediately, go to an emergency department. Vision changes, facial drooping, weakness, difficulty speaking, breathing difficulty or tongue or throat swelling require emergency hospital care. Do not wait for a routine review.
A doctor may use hyaluronidase to reduce HA filler in some situations, but treatment has its own risks and cannot guarantee complete reversal, the original appearance or restored vision. See our guide to dissolving HA filler and its limitations.
References
- Merz Aesthetics Korea: Belotero Revive composition. Used for formulation information, not Thai indications.
- Kerscher et al. Facial Skin Revitalization with CPM-HA20G. Plastic and Reconstructive Surgery – Global Open, 2021;9:e3973. Merz-sponsored study comparing treatment plans for one product.
- Allergan Aesthetics: Skinvive U.S. Directions for Use, including cheek and neck studies.
- U.S. FDA: Skinvive neck indication, P110033/S099, approved 11 June 2026.
- U.S. FDA: Dermal filler risks and patient information.
- U.S. FDA: 2025 review of dermal filler risks and removal limitations.